CD19 and cancer: Similarly, as IL17 has been shown to have both pro- and anti-tumor effects [11], the induction of TH17 cytokines by GLUTOE in CD19-CAR T cells requires further investigation, and defining its role in driving the therapeutic efficacy of GLUTOE CD19-CAR T cells will provide important insight into the role that IL17 plays in cancer.